← The SEC Ephemeris: the whole map
Zealand Pharma US, Inc. glepaglutide
In the graph: all 2 documents (10 pages).
- Application
- NDA 218828
- Ticker
- Zealand Pharma US, Inc.
- Product
- glepaglutide
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- December 19, 2024 · October 8, 2024
From FDA letters and SEC filings. Not investment or medical advice.